![](https://www.aiche.org/sites/default/files/styles/ache_portrait_no-up-scale_nocrop/public/images/bio/mark.png?itok=8qJz3y_y)
Mark completed his Chemical Engineering undergraduate, PhD and post-doctoral studies from The School of Chemical and Bioprocess Engineering in University College Dublin. These studies focused on discovering new ways to develop and manufacture medicines.
Mark is the Co-Founder and Chief Executive Officer of APC Ltd. a 100% Irish owned pharmaceutical company focused on revolutionizing how new medicines are developed and accelerated to the market. Mark co-founded, with Prof. Brian Glennon, and led APC from its inception, to commercialisation, to global growth.
Independent of any VC or Private Equity APC has grown organically to become a global leader in process development, partnering with companies large and small to bring medicines to market at unprecedented speed. APC now employs over 140 scientists, engineers and pharmaceutical professionals across Ireland and the US and aims to double in size in the coming 3 years.
APC is bound by its cultural commitment to redefine patient possibilities through best-in-class science and first-in-class digital technologies.